DA
Therapeutic Areas
Hikma Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Injectables Portfolio Pipeline | Various (Oncology, CV, Anti-infective) | ANDA Filed/Development |
| Generics Oral Portfolio Pipeline | Various (CNS, CV, etc.) | ANDA Filed/Development |
| Branded MENA Portfolio | Chronic Diseases (Diabetes, Respiratory, Cardiology) | Approved/Registration |
Leadership Team at Hikma Pharmaceuticals
SD
Said Darwazah
Executive Chairman
RM
Riad Mishlawi
Chief Executive Officer (CEO)
KN
Khalid Nabilsi
Chief Financial Officer (CFO)
BH
Brian Hoffmann
President, Generics Division
MM
Michael McDonnell
President, Injectables Division
MD
Mazen Darwazah
President, MENA and Executive Vice Chairman, Global Strategic Businesses
DS
Dr. Susan Ring
Chief Human Resources Officer
BK
Bassam Kanaan
Chief Corporate Development Officer
MZ
Mona Zind
General Counsel & Company Secretary
S(
Sigurdur (Siggi) Olafsson
Non-Executive Director